IRDAI Clarifies How Insurers Can Invest in Alternative Investment Funds Without Breaching Section 27E

On 12 February 2026, the Insurance Regulatory and Development Authority of India (IRDAI) issued circular Ref IRDAI/F&I/CIR/INV/28/2/2026, titled "Clarifications on provisions with respect to investment in Alternative Investment Funds (AIFs)". The circular does not create a new permission; it settles how insurers may use an existing one without tripping over Section 27E of the Insurance Act, 1938, a provision whose breach is penalised under Section 104 of the same Act. For an industry that had been asking since 2024 how to widen its AIF exposure through Fund of Funds (FoF) structures, the clarification is the difference between a compliant allocation and a voided one.

This deep dive explains the statutory framework the 12 February 2026 circular rests on, why a back-office investment rule reaches all the way to your policy, the arithmetic an insurer's investment committee must run before it commits a rupee, and the compliance traps that still catch unwary funds.

The Rule / Product

The permission the circular governs lives in para 1.5 of the IRDAI Master Circular on Actuarial, Finance and Investment Functions of Insurers, dated 17 May 2024. That Master Circular allows insurers to invest in AIFs, which the Securities and Exchange Board of India (SEBI) defines as privately pooled vehicles with a minimum investor commitment of Rs 1 crore, sorted into Category I (venture capital, infrastructure, social ventures), Category II (private equity, debt funds) and Category III (hedge funds and complex trading strategies). The permission is hedged by one hard statutory wall: Section 27E of the Insurance Act, 1938.

Section 27E is short and absolute. It states that "no insurer shall directly or indirectly invest outside India the funds of the policyholders". The word "indirectly" is the whole problem the 12 February 2026 circular addresses. An insurer that buys units in a domestic FoF has not invested abroad in the obvious sense, but if that FoF, or an AIF the FoF holds, in turn holds securities of a company incorporated outside India, the insurer has invested policyholder money abroad indirectly, and has contravened Section 27E.

To close that leak, para 1.5 of the 17 May 2024 Master Circular imposes four structural conditions that the 12 February 2026 circular reaffirms and operationalises. The table below sets out the three instruments that now govern an insurer's AIF allocation.

The four conditions, read together, say this. First, an insurer may invest only in a FoF that itself complies with Section 27E of the Insurance Act, 1938. Second, that FoF must carry a clause in its fund documents preventing it from investing in any AIF that in turn invests in foreign companies or foreign funds. Third, the underlying AIFs must not hold securities of companies incorporated outside India. Fourth, no insurer may invest in an AIF that already has exposure to another FoF in which the same insurer holds a position, a rule designed to stop circular, double-counted exposure.

The 12 February 2026 circular layers one more thing on top, referencing SEBI circular SEBI/HO/AFD-1/POD/P/CIR/2023/053 dated 10 April 2023: it tells insurers how to treat AIFs that carry "excuse rights", the contractual right of an investor to opt out of a particular investment, and how to count investee-level limits for both direct and indirect exposure through a FoF. The regulator's answer is documentary rigour rather than new numeric caps.

Why It Matters

The money at stake is not marginal. Indian insurers managed assets running into lakhs of crores as at the FY 2024-25 disclosures filed with IRDAI, and the industry's appetite for the illiquid, higher-yielding exposures that AIFs offer has been growing since the 17 May 2024 Master Circular formalised the route. Every rupee an insurer earns on a well-structured AIF allocation ultimately supports the bonuses on participating policies, the solvency cushion behind guaranteed products, and the pricing of the next cohort of policies.

The reason this reaches a retail policyholder is that insurance is a promise discounted over decades, and the quality of that promise depends on where reserves sit. When you buy a term plan or compare a ULIP against a mutual fund, you are trusting the insurer to invest the premium prudently and keep it inside the ring-fence the law draws around policyholder funds. Section 27E is that ring-fence, and the 12 February 2026 circular is the regulator making sure a fashionable asset class does not quietly breach it.

There is a governance dividend too. The circular, dated 12 February 2026, forces an insurer to put its Section 27E compliance in writing before it invests, rather than discovering a foreign-exposure breach at audit. An AIF carries a 3-to-7-year lock-in and limited NAV transparency, so a breach found three years in cannot be unwound cheaply. Documenting compliance up front, as the circular requires, converts an open-ended tail risk into a one-time diligence cost.

Finally, the clarification matters because SEBI and IRDAI are now visibly coordinating. By referencing SEBI's 10 April 2023 circular inside an IRDAI investment circular dated 12 February 2026, the regulator is aligning the securities-market definition of AIF conduct with the insurance-law limit on offshore exposure, reducing the regulatory arbitrage that a split framework would otherwise invite.

Worked Numbers

The 12 February 2026 circular does not publish new percentage caps, so the arithmetic that matters is the exposure-tracing calculation an insurer's investment committee must run. The figures below are illustrative, chosen to show the mechanics the circular demands, not actual regulatory ceilings.

Suppose a life insurer proposes to commit Rs 200 crore of policyholder funds to a domestic Fund of Funds with a total corpus of Rs 1,000 crore. That commitment represents 20 per cent of the FoF. The FoF spreads its Rs 1,000 crore across five underlying Category II AIFs, allocating Rs 150 crore to one of them. The insurer's look-through exposure to that single underlying AIF is therefore its 20 per cent share of the FoF's Rs 150 crore holding, which is Rs 30 crore.

Now assume that underlying AIF proposes to put 8 per cent of its portfolio into equity of a company incorporated in Singapore. Traced through, the insurer's indirect offshore exposure would be 8 per cent of its Rs 30 crore look-through position, or Rs 2.4 crore of policyholder money invested abroad. Under Section 27E of the Insurance Act, 1938, the permitted figure for that line is exactly Rs 0. The table below sets out the trace.

Because the permitted figure is zero, the insurer cannot complete the Rs 200 crore commitment as structured. The 12 February 2026 circular gives it two documented routes. The first is to rely on the FoF's mandatory fund-document clause that bars the FoF from holding any AIF which invests in foreign companies or funds, so the offending AIF never enters the FoF in the first place. The second, where the AIF is already held, is to exercise the "excuse rights" recognised under SEBI circular SEBI/HO/AFD-1/POD/P/CIR/2023/053 dated 10 April 2023, formally opting the insurer's capital out of the Singapore investment so that the traced figure returns to Rs 0.

The cost of getting this wrong is not a fine alone. A contravention of Section 27E is penalised under Section 104 of the Insurance Act, 1938, and an AIF commitment locked for 3 to 7 years cannot be reversed on demand, so a Rs 2.4 crore traced breach can sterilise the full Rs 200 crore commitment until the structure is corrected. The arithmetic is small; the lock-in makes it expensive.

Pitfalls

The traps in this regime are structural, and most of them hide one layer below where an insurer is looking. The first is the indirect-exposure blind spot. An insurer may diligence the FoF carefully and still miss that an underlying AIF, two layers down, holds a single offshore line. The 12 February 2026 circular's insistence on a fund-document clause binding the FoF, not merely the insurer, exists precisely because diligence stops too shallow.

The second pitfall is double-counted FoF exposure. The fourth condition in para 1.5 of the 17 May 2024 Master Circular bars an insurer from investing in an AIF that itself has exposure to another FoF in which the insurer already holds a position. An insurer running several mandates can breach this accidentally when two fund managers, acting independently, create a loop back to the same FoF. The only defence is a consolidated, insurer-wide exposure register maintained in real time, not a per-mandate view.

The third pitfall is treating "excuse rights" as automatic. The right to opt out of a specific investment under SEBI circular SEBI/HO/AFD-1/POD/P/CIR/2023/053 dated 10 April 2023 only works if it is actually written into the AIF's contribution agreement and exercised in time. An insurer that assumes excuse rights exist, without confirming the clause, has no exit when the offshore line appears.

The fourth pitfall is documentation that lags the investment. The 12 February 2026 circular requires three specific records before an insurer widens its AIF exposure, summarised below. An allocation made before these exist is non-compliant even if the underlying economics are clean.

The three mandatory documents are, first, a formal declaration citing Section 27E of the Insurance Act, 1938, confirming no direct or indirect offshore exposure; second, the specific private placement memorandum (PPM) clauses that bar foreign investment at the FoF and AIF level; and third, a statutory auditor's confirmation that the structure complies. Missing any one of the three leaves the insurer exposed under Section 104 even where no rupee has actually gone abroad, because the regulator treats the absence of documented compliance as the breach.

A final, quieter trap applies to how insurers explain their reserves to policyholders. None of this changes the protection you buy; a health insurance claim or a death benefit is paid from reserves whose offshore exposure is capped at zero by Section 27E regardless of how the AIF layer is structured. The pitfall is institutional, not personal, and that distinction is worth stating plainly.

FAQ

What is Section 27E of the Insurance Act, 1938?

Section 27E provides that no insurer shall directly or indirectly invest outside India the funds of the policyholders. It is an absolute prohibition on offshore investment of policyholder money, and its contravention is penalised under Section 104 of the same Act. The 12 February 2026 IRDAI circular exists to help insurers invest in AIFs without breaching it indirectly.

Does the 12 February 2026 circular let insurers invest more in AIFs?

It widens the opportunity by clarifying the conditions rather than by raising a numeric cap. Circular IRDAI/F&I/CIR/INV/28/2/2026, dated 12 February 2026, tells insurers how to treat excuse rights and how to count direct and indirect exposure through a Fund of Funds, so that allocations which were previously left uncertain can now proceed on a documented basis.

Can an insurer invest directly in any AIF, or only through a Fund of Funds?

Under para 1.5 of the IRDAI Master Circular dated 17 May 2024, the route the circular governs is investment in a Fund of Funds that complies with Section 27E, with the FoF carrying a clause preventing it from holding AIFs that invest in foreign companies or funds. The underlying AIFs must not hold securities of companies incorporated outside India.

What are "excuse rights" and why do they matter here?

Excuse rights, recognised under SEBI circular SEBI/HO/AFD-1/POD/P/CIR/2023/053 dated 10 April 2023, are an investor's contractual right to opt out of a particular investment made by an AIF. For an insurer, they are the mechanism to avoid an offshore line that would breach Section 27E, provided the right is written into the agreement and exercised in time.

What documents must an insurer keep before investing?

The 12 February 2026 circular requires a formal declaration citing Section 27E confirming no offshore exposure, the specific private placement memorandum clauses barring foreign investment at the FoF and AIF level, and a statutory auditor's confirmation of compliance. All three must exist before the allocation is made.

Does any of this affect the policy I hold?

Not directly. Your claim or maturity benefit is paid from reserves whose offshore exposure is held at zero by Section 27E, regardless of the AIF structure behind them. The 12 February 2026 clarification is about how insurers manage those reserves prudently, which supports the long-term strength of the promise rather than changing any term of your policy.

What happens if an insurer breaches Section 27E through an AIF?

A contravention of Section 27E is penalised under Section 104 of the Insurance Act, 1938. Because AIFs carry a 3-to-7-year lock-in, a breach discovered after the commitment is made cannot be unwound quickly, which is why the 12 February 2026 circular front-loads the compliance into documentation required before the investment.